226 related articles for article (PubMed ID: 28299705)
1. Characterization of In Vivo Selected Bacteriophage for the Development of Novel Tumor-Targeting Agents with Specific Pharmacokinetics and Imaging Applications.
Newton-Northup J; Deutscher SL
Methods Mol Biol; 2017; 1572():445-465. PubMed ID: 28299705
[TBL] [Abstract][Full Text] [Related]
2. In vivo bacteriophage display for the discovery of novel peptide-based tumor-targeting agents.
Newton JR; Deutscher SL
Methods Mol Biol; 2009; 504():275-90. PubMed ID: 19159103
[TBL] [Abstract][Full Text] [Related]
3. In vivo bacteriophage peptide display to tailor pharmacokinetics of biological nanoparticles.
Newton-Northup JR; Dickerson MT; Kumar SR; Smith GP; Quinn TP; Deutscher SL
Mol Imaging Biol; 2014 Dec; 16(6):854-64. PubMed ID: 25001195
[TBL] [Abstract][Full Text] [Related]
4. Streamlined in vivo selection and screening of human prostate carcinoma avid phage particles for development of peptide based in vivo tumor imaging agents.
Newton-Northup JR; Figueroa SD; Deutscher SL
Comb Chem High Throughput Screen; 2011 Jan; 14(1):9-21. PubMed ID: 20958260
[TBL] [Abstract][Full Text] [Related]
5. Selection of Cancer Stem Cell-Targeting Agents Using Bacteriophage Display.
Prater AR; Deutscher SL
Methods Mol Biol; 2022; 2394():787-810. PubMed ID: 35094358
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells.
Dmitrieva MD; Voitova AA; Dymova MA; Richter VA; Kuligina EV
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396774
[TBL] [Abstract][Full Text] [Related]
7. Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.
Larimer BM; Thomas WD; Smith GP; Deutscher SL
Mol Imaging Biol; 2014 Aug; 16(4):449-58. PubMed ID: 24550054
[TBL] [Abstract][Full Text] [Related]
8. In vitro high throughput phage display selection of ovarian cancer avid phage clones for near-infrared optical imaging.
Soendergaard M; Newton-Northup JR; Deutscher SL
Comb Chem High Throughput Screen; 2014; 17(10):859-67. PubMed ID: 25360673
[TBL] [Abstract][Full Text] [Related]
9. Phage display and molecular imaging: expanding fields of vision in living subjects.
Cochran R; Cochran F
Biotechnol Genet Eng Rev; 2010; 27():57-94. PubMed ID: 21415893
[TBL] [Abstract][Full Text] [Related]
10. Improving Pharmacokinetics of Peptides Using Phage Display.
Asar M; Newton-Northup J; Soendergaard M
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675913
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial discovery of tumor targeting peptides using phage display.
Landon LA; Deutscher SL
J Cell Biochem; 2003 Oct; 90(3):509-17. PubMed ID: 14523985
[TBL] [Abstract][Full Text] [Related]
12. Near-infrared-labeled peptide multimer functions as phage mimic for high affinity, specific targeting of colonic adenomas in vivo (with videos).
Joshi BP; Liu Z; Elahi SF; Appelman HD; Wang TD
Gastrointest Endosc; 2012 Dec; 76(6):1197-206.e1-5. PubMed ID: 23022051
[TBL] [Abstract][Full Text] [Related]
13. Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.
Loi M; Di Paolo D; Soster M; Brignole C; Bartolini A; Emionite L; Sun J; Becherini P; Curnis F; Petretto A; Sani M; Gori A; Milanese M; Gambini C; Longhi R; Cilli M; Allen TM; Bussolino F; Arap W; Pasqualini R; Corti A; Ponzoni M; Marchiò S; Pastorino F
J Control Release; 2013 Sep; 170(2):233-41. PubMed ID: 23714122
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of filamentous phage peptide libraries in mice.
Zou J; Dickerson MT; Owen NK; Landon LA; Deutscher SL
Mol Biol Rep; 2004 Jun; 31(2):121-9. PubMed ID: 15293788
[TBL] [Abstract][Full Text] [Related]
15. A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1-Overexpressing Tumors in vivo.
Haque ME; Khan F; Chi L; Gurung S; Vadevoo SMP; Park RW; Kim DK; Kim SK; Lee B
Cancer Res Treat; 2019 Jul; 51(3):861-875. PubMed ID: 30282451
[TBL] [Abstract][Full Text] [Related]
16. Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synovium.
Burtea C; Laurent S; Sanli T; Fanfone D; Devalckeneer A; Sauvage S; Beckers MC; Rorive S; Salmon I; Vander Elst L; Lauwerys BR; Muller RN
Arthritis Res Ther; 2016 Oct; 18(1):230. PubMed ID: 27729062
[TBL] [Abstract][Full Text] [Related]
17. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
[TBL] [Abstract][Full Text] [Related]
18. Identification of chondrocyte-binding peptides by phage display.
Cheung CS; Lui JC; Baron J
J Orthop Res; 2013 Jul; 31(7):1053-8. PubMed ID: 23440926
[TBL] [Abstract][Full Text] [Related]
19. Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors.
Kennel SJ; Mirzadeh S; Hurst GB; Foote LJ; Lankford TK; Glowienka KA; Chappell LL; Kelso JR; Davern SM; Safavy A; Brechbiel MW
Nucl Med Biol; 2000 Nov; 27(8):815-25. PubMed ID: 11150716
[TBL] [Abstract][Full Text] [Related]
20. Phage Display Selection, Identification, and Characterization of Novel Pancreatic Cancer Targeting Peptides.
Asar MC; Franco A; Soendergaard M
Biomolecules; 2020 May; 10(5):. PubMed ID: 32380649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
